ENLV

NASDAQ · Equity

Enlivex Therapeutics Ltd

US Healthcare Biotechnology

Latest week
29 May 2026
Close
0.810300
Fair value
1.533799
Expectation
Negative 39.13%
Weekly Close Trend Line Fair Value Activity Lines

Chart Summary

Key Points

Week Ending
29 May 2026
Latest Close
0.81
12-Week Change
-22.09%
Trend Signal
Inactive
Expectation
Negative 39.13%
Signal Weeks
0 of 12
Vs Trend Line
Below
Vs Fair Value
Below
Relative Strength
-36.73
Market Dynamics
-1.05

Over the latest 12 completed weeks ending 2026-05-29, ENLV fell 22.09%, moving from 1.04 to 0.81. The latest weekly close is below the Trend Line and below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 12 weeks. Relative Strength is -36.73 and has softened across the 12-week window. Market Dynamics is -1.05 on the latest week. Expectation is negative at 39.13%.